191 related articles for article (PubMed ID: 33577137)
1. The diagnostic and prognostic significance of flow cytometric bone marrow assessment in myelodysplastic syndromes according to the European LeukemiaNet recommendations in single-centre real-life experience.
Majcherek M; Kiernicka-Parulska J; Mierzwa A; Barańska M; Matuszak M; Lewandowski K; Komarnicki M; Czyż A
Scand J Immunol; 2021 Aug; 94(2):e13028. PubMed ID: 33577137
[TBL] [Abstract][Full Text] [Related]
2. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
[TBL] [Abstract][Full Text] [Related]
3. The utility of a single tube 10-color flow cytometry for quantitative and qualitative analysis in myelodysplastic syndrome- a pilot study.
Chauhan R; Singh J; Sharma C; Dange P; Chopra A; Mahapatra M; Pati H
Leuk Res; 2021 Aug; 107():106651. PubMed ID: 34218155
[TBL] [Abstract][Full Text] [Related]
4. A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome.
Chung JW; Park CJ; Cha CH; Cho YU; Jang S; Chi HS; Seo EJ; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
Ann Clin Lab Sci; 2012; 42(3):271-80. PubMed ID: 22964615
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of the lymphoid screening tube supplemented with CD34 for Ogata score calculation in patients with peripheral cytopenia.
Muyldermans A; Florin L; Devos H; Cauwelier B; Emmerechts J
Hematology; 2019 Dec; 24(1):166-172. PubMed ID: 30334700
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic significance of immunophenotyping of bone marrow cells in myelodysplastic syndrome without an increase of marrow blasts].
Xu J; Zhang W; Liu Y; Wan SG; Sun XJ; Zhao H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1477-81. PubMed ID: 20030930
[TBL] [Abstract][Full Text] [Related]
7. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
Porwit A; Béné MC; Duetz C; Matarraz S; Oelschlaegel U; Westers TM; Wagner-Ballon O; Kordasti S; Valent P; Preijers F; Alhan C; Bellos F; Bettelheim P; Burbury K; Chapuis N; Cremers E; Della Porta MG; Dunlop A; Eidenschink-Brodersen L; Font P; Fontenay M; Hobo W; Ireland R; Johansson U; Loken MR; Ogata K; Orfao A; Psarra K; Saft L; Subira D; Te Marvelde J; Wells DA; van der Velden VHJ; Kern W; van de Loosdrecht AA
Cytometry B Clin Cytom; 2023 Jan; 104(1):27-50. PubMed ID: 36537621
[TBL] [Abstract][Full Text] [Related]
8. Multicenter comparison of CD34+ myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?
Font P; Subirá D; Matarraz S; Benavente C; Cedena MT; Morado M; Pérez Corral A; Bellón JM; Díez-Martín JL
Cytometry B Clin Cytom; 2018 May; 94(3):527-535. PubMed ID: 28618451
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes.
Davydova YO; Parovichnikova EN; Galtseva IV; Kokhno AV; Dvirnyk VN; Kovrigina AM; Obukhova TN; Kapranov NM; Nikiforova KA; Glinkina SA; Troitskaya VV; Mikhailova EA; Fidarova ZT; Moiseeva TN; Lukina EA; Tsvetaeva NV; Nikulina OF; Kuzmina LA; Savchenko VG
Cytometry B Clin Cytom; 2021 May; 100(3):312-321. PubMed ID: 33052634
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic clustering of myelodysplastic syndromes.
Maynadié M; Picard F; Husson B; Chatelain B; Cornet Y; Le Roux G; Campos L; Dromelet A; Lepelley P; Jouault H; Imbert M; Rosenwadj M; Vergé V; Bissières P; Raphaël M; Béné MC; Feuillard J;
Blood; 2002 Oct; 100(7):2349-56. PubMed ID: 12239142
[TBL] [Abstract][Full Text] [Related]
12. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
[TBL] [Abstract][Full Text] [Related]
13. High Ia (HLA-DR) and low CD11b (Mo1) expression may predict early conversion to leukemia in myelodysplastic syndromes.
Mittelman M; Karcher DS; Kammerman LA; Lessin LS
Am J Hematol; 1993 Jul; 43(3):165-71. PubMed ID: 8352230
[TBL] [Abstract][Full Text] [Related]
14. High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes.
Alhan C; Westers TM; Cremers EM; Cali C; Witte BI; Ossenkoppele GJ; van de Loosdrecht AA
Br J Haematol; 2014 Oct; 167(1):100-9. PubMed ID: 24976502
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of immunophenotypic features of blasts in patients with myelodysplastic syndrome by flow cytometry and its diagnostic significance].
Sun JF; Yang B; Zhang L; Huang Y; Yang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):632-5. PubMed ID: 22739171
[TBL] [Abstract][Full Text] [Related]
16. Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
Ogata K; Sei K; Saft L; Kawahara N; Porta MGD; Chapuis N; Yamamoto Y
Leuk Res; 2018 Aug; 71():75-81. PubMed ID: 30025279
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Flow Cytometry Standardized Using the European LeukemiaNet for Myelodysplastic Syndrome.
Takeuchi A; Imataki O; Kubo H; Kondo A; Seo K; Uemura M; Yamaoka G; Murao K; Takeuchi A
Acta Haematol; 2020; 143(2):140-145. PubMed ID: 31330512
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry immunophenotyping in integrated diagnostics of patients with newly diagnosed cytopenia: one tube 10-color 14-antibody screening panel and 3-tube extensive panel for detection of MDS-related features.
Porwit A; Rajab A
Int J Lab Hematol; 2015 May; 37 Suppl 1():133-43. PubMed ID: 25976971
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.
Falco P; Levis A; Stacchini A; Ciriello MM; Geuna M; Notari P; Omedè P; Pautasso M; Prato G; Strola G; Gioia D; Bonferroni M; Cametti G; Ferrero D; Freilone R; Gaidano G; Marinone C; Marmont F; Pollio B; Salvi F; Saglio G; Girotto M;
Eur J Haematol; 2011 Nov; 87(5):409-18. PubMed ID: 21711395
[TBL] [Abstract][Full Text] [Related]
20. Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.
Alhan C; Westers TM; Cremers EM; Cali C; Ossenkoppele GJ; van de Loosdrecht AA
Cytometry B Clin Cytom; 2016 Jul; 90(4):358-67. PubMed ID: 26517178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
